utritional Improvement and Mechanism of Liver Cancer Treatment Using Edible Insects
Not Applicable
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0005437
- Lead Sponsor
- Yonsei University Health System, Gangnam Severance Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
1) a patient between ages of 18 and 85
2) Patients schelduled for surgery with pancreatobiliary disease and liver cancer (HCC, CCC, and metastatic liver cancer)
3) Karnofsky Performance status = 70
4) Patients who provide informed consent
Exclusion Criteria
Exclusions for patients with any of the following creteria
1) Patients who underwent palliative surgery
2) Patients with uncontrolled preoperative conditions
3) Previous history of surgery affecting nutritional status (ex, gastrectomy, colectomy, etc)
4) Pregnant and lactating women
5) Patients with an allergy to mealworms
6) Patients with a hematological abnormalty
- Total bilirubin > 1.5 X upper normal limit
- ALT, AST > 2.5 X upper normal limit
- ALP > 2.5 X upper normal limit
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method utritional marker (phase angle, muscle mass, fat free mass, fat mass, body cell mass)
- Secondary Outcome Measures
Name Time Method Hematologic test (Hemoglobin, Hematocrit, Platelet, WBC, Neutrophil ?);Biochemical test (Total protein, Albumin, Glucose, BUN, Creatinin, Total bilirubin, AST, ALT)